BRIDGEWATER, NJ--(Marketwire - February 12, 2008) - Sapphire Therapeutics, Inc., a private biopharmaceutical company that develops compounds acting within the ghrelin pathway as treatments for metabolic, oncologic, and gastrointestinal diseases, today announced the promotion of Suzan Allen to Vice President Clinical Operations.
